🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
X-CEED-OLE is a Phase 3, multicenter, open-label study to evaluate the long...
Status
Enrolling By Invitation
Location
Woodland International Research Group
Start Date
2025-10-30
Trial ID
NCT07217860
Treatments Being Tested
The X-TOLE3 Phase 3 clinical trial is a randomized, double-blind, placebo-c...
Status
Recruiting
Location
Clinical Trials, Inc.
Start Date
2023-05-09
Trial ID
NCT05716100
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Recruiting
Location
University of Alabama - Strada Patient Care Center, Neurology
Start Date
2023-02-14
Trial ID
NCT05667142
This study will evaluate the long term safety, tolerability, pharmacokineti...
Status
Enrolling By Invitation
Location
Xenoscience
Start Date
2023-04-25
Trial ID
NCT05718817
Treatments Being Tested
The X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-c...
Status
Completed
Location
Strada Patient Care Center
Start Date
2022-11-18
Trial ID
NCT05614063
X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Noble Clinical Research
Start Date
2025-08-08
Trial ID
NCT07172516
Treatments Being Tested
X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
Harmonex Neuroscience Research
Start Date
2025-07-08
Trial ID
NCT07076407
Treatments Being Tested
X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
IMA Clinical Research Phoenix
Start Date
2024-12-20
Trial ID
NCT06775379
Treatments Being Tested
X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term saf...
Status
Enrolling By Invitation
Location
Ima Clinical Research - Phoenix
Start Date
2025-03-18
Trial ID
NCT06922110
Treatments Being Tested